LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Geschlossen

4.19 -1.18

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.08

Max

4.19

Schlüsselkennzahlen
By Trading Economics
Einkommen	410K -4.2M
Gewinnspanne	-6,655.714
Angestellte	26

Dividenden
By Dow Jones
Nächstes Ergebnis	12. März 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	11M 31M
Vorheriger Eröffnungskurs	5.37
Vorheriger Schlusskurs	4.19

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. März 2026, 19:32 UTC

Akquisitionen, Fusionen, Übernahmen

Diana Shipping Increases Offer to Acquire Genco -- Update

6. März 2026, 17:44 UTC

Akquisitionen, Fusionen, Übernahmen

Lonza to Offload Majority Stake in Capsule Business to Lone Star in $2.2 Billion Deal

6. März 2026, 22:26 UTC

Wichtige Nachrichtenereignisse

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

6. März 2026, 22:07 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

6. März 2026, 22:03 UTC

Market Talk

Global Equities Roundup: Market Talk

6. März 2026, 22:03 UTC

Market Talk

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

6. März 2026, 21:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

Financial Services Roundup: Market Talk

6. März 2026, 21:37 UTC

Ergebnisse

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

6. März 2026, 21:25 UTC

Wichtige Nachrichtenereignisse

How The Iran War Impacts Ukraine. -- Barrons.com

6. März 2026, 21:17 UTC

Ergebnisse

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

6. März 2026, 20:50 UTC

Ergebnisse

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

6. März 2026, 20:46 UTC

Ergebnisse

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

6. März 2026, 20:31 UTC

Wichtige Nachrichtenereignisse

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

6. März 2026, 20:18 UTC

Market Talk

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

6. März 2026, 20:12 UTC

Market Talk

Wichtige Nachrichtenereignisse

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

6. März 2026, 19:10 UTC

Market Talk

Wichtige Nachrichtenereignisse

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

6. März 2026, 18:54 UTC

Market Talk

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

6. März 2026, 18:44 UTC

Market Talk

Wichtige Nachrichtenereignisse

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

6. März 2026, 18:08 UTC

Ergebnisse

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6. März 2026, 18:04 UTC

Ergebnisse

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6. März 2026, 18:04 UTC

Ergebnisse

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6. März 2026, 17:49 UTC

Market Talk

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

6. März 2026, 17:46 UTC

Wichtige Nachrichtenereignisse

Kuwait Cuts Oil Production as Fallout From Iran Conflict Intensifies -- Update

6. März 2026, 17:40 UTC

Market Talk

Ergebnisse

Marvell's Long-Term Outlook Well-Received By Investors -- Market Talk

6. März 2026, 17:40 UTC

Ergebnisse

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6. März 2026, 17:32 UTC

Market Talk

Wichtige Nachrichtenereignisse

No Quick Solution for Hormuz Shipping as U.S. Oil Tops $90 -- Market Talk

6. März 2026, 17:28 UTC

Market Talk

Wichtige Nachrichtenereignisse

Aluminum Rising as Strait of Hormuz Stays Locked -- Market Talk

6. März 2026, 17:20 UTC

Market Talk

Ergebnisse

Auto & Transport Roundup: Market Talk

6. März 2026, 17:20 UTC

Market Talk

Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

6. März 2026, 17:20 UTC

Akquisitionen, Fusionen, Übernahmen

BlackRock Sticks to Redemption Minimum on Credit Fund, Sends Shares Lower -- WSJ

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.